Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.6 EUR | +0.26% | +5.36% | -37.13% |
May. 29 | THYSSENKRUPP NUCERA : RBC reaffirms its Buy rating | ZD |
May. 27 | Bernstein rates Thyssenkrupp Nucera at 'Outperform' | DP |
Valuation
Fiscal Period: September | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Capitalization 1 | 2,346 | 1,465 | - | - |
Enterprise Value (EV) 1 | 1,583 | 801.7 | 885.3 | 912.6 |
P/E ratio | 88.4 x | -47.6 x | 62.6 x | 30.5 x |
Yield | - | - | - | 0.11% |
Capitalization / Revenue | 3.59 x | 1.63 x | 1.31 x | 1.07 x |
EV / Revenue | 2.43 x | 0.89 x | 0.79 x | 0.67 x |
EV / EBITDA | 55.2 x | -18.7 x | 25.9 x | 12.7 x |
EV / FCF | -88 x | -5.16 x | -12.2 x | 52 x |
FCF Yield | -1.14% | -19.4% | -8.19% | 1.92% |
Price to Book | 3.15 x | 2.05 x | 2.02 x | 1.91 x |
Nbr of stocks (in thousands) | 126,315 | 126,315 | - | - |
Reference price 2 | 18.57 | 11.60 | 11.60 | 11.60 |
Announcement Date | 12/18/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: September | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | - | 652.8 | 899 | 1,117 | 1,368 |
EBITDA 1 | - | 28.7 | -42.79 | 34.12 | 71.71 |
EBIT 1 | - | 23.8 | -46.89 | 17.77 | 52.91 |
Operating Margin | - | 3.65% | -5.22% | 1.59% | 3.87% |
Earnings before Tax (EBT) 1 | - | 34.4 | -23.18 | 26.72 | 55.73 |
Net income 1 | 6.038 | 22.5 | -32.4 | 24.39 | 48.04 |
Net margin | - | 3.45% | -3.6% | 2.18% | 3.51% |
EPS 2 | - | 0.2100 | -0.2436 | 0.1852 | 0.3801 |
Free Cash Flow 1 | - | -18 | -155.4 | -72.46 | 17.53 |
FCF margin | - | -2.76% | -17.28% | -6.49% | 1.28% |
FCF Conversion (EBITDA) | - | - | - | - | 24.45% |
FCF Conversion (Net income) | - | - | - | - | 36.5% |
Dividend per Share 2 | - | - | - | - | 0.0125 |
Announcement Date | 6/23/23 | 12/18/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: September | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | 159.4 | 208.3 | 168 | 376.3 | 241.2 | 248.6 |
EBITDA 1 | - | - | 0.4 | -9.1 | - | -13.12 | -19.28 |
EBIT 1 | - | 3.5 | -0.9 | -10.6 | -11.4 | -14.12 | -19.74 |
Operating Margin | - | 2.2% | -0.43% | -6.31% | -3.03% | -5.85% | -7.94% |
Earnings before Tax (EBT) | - | 9.1 | 4.9 | -4.5 | - | - | - |
Net income 1 | 6.1 | 4.3 | 2.8 | -7.2 | -4.4 | -5.684 | -9.587 |
Net margin | - | 2.7% | 1.34% | -4.29% | -1.17% | -2.36% | -3.86% |
EPS 2 | - | - | 0.0200 | -0.0600 | - | -0.0625 | -0.1429 |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 8/28/23 | 12/18/23 | 2/13/24 | 5/15/24 | 5/15/24 | - | - |
Balance Sheet Analysis
Fiscal Period: September | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - |
Net Cash position 1 | - | 762 | 664 | 580 | 553 |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow 1 | - | -18 | -155 | -72.5 | 17.5 |
ROE (net income / shareholders' equity) | - | 4.7% | -2.51% | 2.7% | 5.15% |
ROA (Net income/ Total Assets) | - | 2.7% | -1.45% | 1.48% | 2.23% |
Assets 1 | - | 833.3 | 2,232 | 1,644 | 2,151 |
Book Value Per Share 2 | - | 5.900 | 5.670 | 5.730 | 6.070 |
Cash Flow per Share 2 | - | -0.1300 | -0.5000 | -0.1400 | 0.5400 |
Capex 1 | - | 3.8 | 51 | 69.6 | 71.4 |
Capex / Sales | - | 0.58% | 5.67% | 6.23% | 5.22% |
Announcement Date | 6/23/23 | 12/18/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.13% | 1.59B | |
+14.10% | 10.86B | |
+39.60% | 2.19B | |
+62.33% | 1.96B | |
-13.89% | 1.72B | |
+16.15% | 1.05B | |
-8.72% | 721M | |
-3.81% | 666M | |
-30.60% | 647M | |
+23.27% | 521M |
- Stock Market
- Equities
- NCH2 Stock
- Financials thyssenkrupp nucera AG & Co. KGaA